RE:RE:Quick summary points from a very busy guypalinc2000 wrote: SPCEO1 wrote: - At the annual meeting the company noted the following:
- They have about 100 patients on the drug after 2 ½ weeks after sales began – a very nice start
- The pace of new prescriptions coming in is accelerating
- About 25% of those insured by private insurance in the US are currently covered as reimbursement approvals have come faster than anticipated
- 250 clinics have submitted paperwork to be able to write Trogarzo prescriptions
- Medicare patients can now get Trogarzo (although this remains a complicated process at this point)
- About 20% of the Medicaid population is now covered by Trogarzo
- THERF is days away from gaining coverage for about 10% of expected patients who will eventually take Trogarzo via a program for poorer patients called ADAP
- Luc referred to this progress as “amazingly good”
100 patients in first 2.5 weeks
almost 7 weeks for the additional 100
increasing pace? ???
I think the "accelerating" statement was likely uncharacteristic rashness. Some perspective. The drug had been on the market for 16 days. The whole process of getting payors on board was going very well as was the interest from clinics. I think thera can be forgiven for thinking the process was accelerating at that early stage. I'm not sure we should get too worried (yet) about trends over a few weeks its going to be a bumpy ride for sure. Overall the start is still pretty strong.